STAT » Alzheimer’s
STAT » Alzheimer’s
6 FOLLOWERS
Get to know about the latest on Alzheimer's drug research from the top pharmaceutical companies and researchers on the mission to finding effective treatments against the disease. STAT delivers trusted and authoritative journalism about health, medicine, and the life sciences. Our journalists go deep in tough-minded coverage of the business of making medicines, health tech, science, and..
STAT Plus: Duchenne gene therapy setback, Alzheimer’s drug endorsement & why a STAT reporter buys weed (for journalism)
STAT » Alzheimer’s
by
1M ago
..read more
Visit website
STAT Plus: FDA advisers unanimously recommend approval of Eli Lilly’s Alzheimer’s disease treatment
STAT » Alzheimer’s
by
1M ago
..read more
Visit website
STAT Plus: FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted to a smaller group
STAT » Alzheimer’s
by
2M ago
..read more
Visit website
How one Colombian family could solve some of Alzheimer’s mysteries
STAT » Alzheimer’s
by
3M ago
..read more
Visit website
STAT Plus: Biogen’s Alzheimer’s drug launch on ‘steady pace’ as logistical hurdles recede
STAT » Alzheimer’s
by
3M ago
..read more
Visit website
Medicare expects a big spike in spending on Leqembi
STAT » Alzheimer’s
by
4M ago
..read more
Visit website
STAT Plus: Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025
STAT » Alzheimer’s
by
4M ago
..read more
Visit website
STAT Plus: A deep dive into Applied Therapeutics’ data, and questions on Cassava’s erased data
STAT » Alzheimer’s
by
5M ago
..read more
Visit website
What STAT readers think about Aduhelm, CTE and the Super Bowl, and more
STAT » Alzheimer’s
by
5M ago
..read more
Visit website
STAT Plus: Years after a polarizing approval, Biogen walks away from Aduhelm
STAT » Alzheimer’s
by
6M ago
..read more
Visit website

Follow STAT » Alzheimer’s on FeedSpot

Continue with Google
Continue with Apple
OR